The affected products are all Nurtec (rimegepant) orally disintegrating tablets, 75 milligram, eight-unit dose blister packs with expiration dates through June 2026.
Because the blister card is not child resistant, there is a risk of poisoning if the contents are swallowed by young children. No injuries have been reported.
Pharmacies nationwide have been contacted.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.